US Enforcement 2019: Compounding, Opioids Top Priorities But Beware Of REMS Violations, Too

 
• By Sue Sutter

Drug manufacturer reimbursement support services also are garnering a growing amount of enforcement attention, and misleading promotion - whether on- or off-label - remains on the radar of government investigators.

James Burnham, deputy assistant attorney general in the Department of Justice’s Civil Division
Deputy Assistant AG James Burnham discusses DoJ enforcement priorities at FDLI. • Source: Sue Sutter

More from Compliance

More from Pink Sheet